Status:
UNKNOWN
Circulating lncRNA and CV Morbidities in CKD and ESRD
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Chronic Kidney Disease
End-stage Renal Disease
Eligibility:
All Genders
20-80 years
Brief Summary
Cardiovascular disease is the major cause of morbidity and death in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The mechanisms linking impaired renal function and in...
Detailed Description
Cardiovascular disease is the major cause of morbidity and death in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Patients with CKD and ESRD are at high risk for myoca...
Eligibility Criteria
Inclusion
- Adult patients with various stages 1-5 of CKD will be enrolled at outpatient clinic. Definition and staging of CKD were defined by estimated glomerular filtration rate by the Modification of Diet in Renal Disease study equation.
- Patients with ESRD under maintenance hemodialysis or peritoneal dialysis will also be included.
Exclusion
- age younger than 20 years or older than 80 years.
- pregnant woman.
- patients already received kidney transplantation.
- recent hospitalization within previous one month.
- for ESRD patients, receiving maintenance hemodialysis or peritoneal dialysis for less than 3 months.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT02304471
Start Date
November 1 2014
End Date
December 1 2018
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, Taiwan, 100